AVIFAVIR in Treating Patients with Moderate COVID 19

Clin Infect Dis. 2021 Aug 2;73(3):e847. doi: 10.1093/cid/ciaa1601.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antiviral Agents